Citation Impact
Citing Papers
A Gene Network Regulating Lysosomal Biogenesis and Function
2009 StandoutScience
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Normal gut microbiota modulates brain development and behavior
2011 Standout
Sleep Drives Metabolite Clearance from the Adult Brain
2013 StandoutScience
Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
2012
Neuronal localization of C1q in preclinical Alzheimer's disease
2003
Microglia as a Potential Bridge between the Amyloid β‐Peptide and Tau
2004
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
1995
Prion protein is necessary for normal synaptic function
1994 Nature
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Inflammation and Alzheimer's disease
2000 Standout
Inflammatory processes in Alzheimer's disease
2007
Cognitive dysfunction in mice deficient for TNF‐ and its receptors
2008
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
Apoptosis in the nervous system
2000 StandoutNature
Temporal expression of IL-1β protein and mRNA in the brain after systemic LPS injection is affected by age and estrogen
2006
NMR structure of the mouse prion protein domain PrP(121–231)
1996 StandoutNatureNobel
Disease-Specific Induced Pluripotent Stem Cells
2008 Standout
Mechanisms of Neuronal Degeneration in Alzheimer's Disease
1996
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia
1998
Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin
2009
Glutamate uptake
2001 Standout
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Beyond the Dopamine Hypothesis
1989
Traumatic brain injury and Alzheimer's disease: a review
2007
Deficits of [3H]d-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia
1997
Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients
1993
Ubiquitin in homeostasis, development and disease
1995
The high affinity uptake system for excitatory amino acids in the brain
1994
Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia
1994
Functional Imaging of Neural Responses to Expectancy and Experience of Monetary Gains and Losses
2001 StandoutNobel
Driving fast-spiking cells induces gamma rhythm and controls sensory responses
2009 StandoutNature
Amyloid deposition as the central event in the aetiology of Alzheimer's disease
1991 Standout
Neuronal fast oscillations as a target site for psychoactive drugs
2000
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis
1996
Substantia innominata: a notion which impedes clinical–anatomical correlations in neuropsychiatric disorders
1997
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
β-Amyloid-Mediated Inhibition of NMDA Receptor-Dependent Long-Term Potentiation Induction Involves Activation of Microglia and Stimulation of Inducible Nitric Oxide Synthase and Superoxide
2004
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein
1995
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling
2013 StandoutNobel
Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau
1998
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
2008
Heterogeneity and Functional Properties of Subtypes of Sodium-Dependent Glutamate Transporters in the Mammalian Central Nervous System
1996
Rethinking schizophrenia
2010 StandoutNature
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
2007
Flotillin-Dependent Clustering of the Amyloid Precursor Protein Regulates Its Endocytosis and Amyloidogenic Processing in Neurons
2008 StandoutNobel
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia
2008
Excitatory amino acid receptors in the human cerebral cortex: A quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine,l-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites
1989
(3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients
1989
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease
1996
Microglial interleukin-lα expression in human head injury: Correlations with neuronal and neuritic β-amyloid precursor protein expression
1994
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Purification and reconstitution of the sodium- and potassium-coupled glutamate transport glycoprotein from rat brain
1990
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
1998
The four ages of Down syndrome
2006
Glutamate: a new target in schizophrenia?
1990
Alzheimer's Disease
2010 Standout
Increased Neuronal β‐Amyloid Precursor Protein Expression in Human Temporal Lobe Epilepsy: Association with Interleukin‐1α Immunoreactivity
1994
Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
1998
Mechanisms and Functions of Inflammasomes
2014 Standout
S100A6 and S100A11 Are Specific Targets of the Calcium- and Zinc-binding S100B Protein in Vivo
2000
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 Standout
HumanAPOEIsoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
2009
Tannic Acid Is a Natural β-Secretase Inhibitor That Prevents Cognitive Impairment and Mitigates Alzheimer-like Pathology in Transgenic Mice
2012
Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice
2000
Inflammatory mechanisms in Alzheimer's disease
1994
Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease
1999
Genetics of Alzheimer’s Disease
2014
β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury
1993
Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species
2002
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
1992
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid
2005
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
1994 Standout
A miRNA Signature of Prion Induced Neurodegeneration
2008
Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia
2003
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Immunocytochemical distribution of peptidergic and cholinergic fibers in the human amygdala: their depletion in Alzheimer's disease and morphologic alteration in non-demented elderly with numerous senile plaques
1993
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
1996
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
2009
Antibody-Mediated Encephalitis
2018 Standout
Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes
2001
The Glutamate Hypothesis of Schizophrenia
1997
AppGene Dosage Modulates Endosomal Abnormalities of Alzheimer's Disease in a Segmental Trisomy 16 Mouse Model of Down Syndrome
2003
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
1998 Standout
One-Step Assembly of Coordination Complexes for Versatile Film and Particle Engineering
2013 StandoutScience
INFLAMMATION AND ALZHEIMERS DISEASE
2000
Dynamics of Gray Matter Loss in Alzheimer's Disease
2003
5-HT and mechanisms of defence
1991
The effects of a novel NSAID on chronic neuroinflammation are age dependent☆
1999
Neuronal–Glial Interactions Mediated by Interleukin-1 Enhance Neuronal Acetylcholinesterase Activity and mRNA Expression
2000
DNA Damage in Nasal and Brain Tissues of Canines Exposed to Air Pollutants Is Associated with Evidence of Chronic Brain Inflammation and Neurodegeneration
2003
When Fear Is Near: Threat Imminence Elicits Prefrontal-Periaqueductal Gray Shifts in Humans
2007 StandoutScienceNobel
Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus.
1996 StandoutNobel
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
1995
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Norepinephrine: A Neuromodulator That Boosts the Function of Multiple Cell Types to Optimize CNS Performance
2012
Neurotransmitter Transporters in the Central Nervous System
1999
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Prion Diseases and the BSE Crisis
1997 StandoutScienceNobel
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
2005 StandoutScience
Prions
1998 StandoutNobel
Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway
2003
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Interleukin-1 and inflammatory neurodegeneration
2007
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics
1996
Scanning the human proteome for calmodulin-binding proteins
2005 StandoutNobel
Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.
1990
Excitatory Amino Acid Receptors in Schizophrenia
1993
Works of M.C. Royston being referenced
Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression
1998
Alterations in phencyclidine and sigma binding sites in schizophrenic brains
1991
Some morphometric observations on the brains of patients with Down's syndrome: their relationship to age and dementia
1990
Differential synaptic loss in the cortex in Alzheimerʼs disease: a study using archival material
1994
Synaptic degeneration is the primary neuropathological feature in prion disease
1993
Altered β-APP Metabolism After Head Injury and its Relationship to the Aetiology of Alzheimer’s Disease
1996
Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains
1988
Life-long overexpression of S100β in Down’s syndrome: implications for Alzheimer pathogenesis
1998
Increased numbers of βAPP-immunoreactive neurones in the entorhinal cortex after head injury
1994
Ubiquitination as a probe for neurodegeneration in the brain in schizophrenia: The prefrontal cortex
1993
Apolipoprotein E ε2 allele promotes longevity and protects patients with Downʼs syndrome from dementia
1994
Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type
1992
Alzheimer's disease: pathology to potential treatments?
1992
Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia
1989
Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia
1992
Reduced GABA uptake sites in the temporal lobe in schizophrenia
1989
A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type
1996
ApoE2 Allele, Down's Syndrome, and Dementiaa
1996
Reduced d-[3H]aspartate binding in Down's syndrome brains
1989
On the origin of Alzheimerʼs disease
1993
Social signalling and schizophrenia: The significance of neurochemical and morphological abnormalities of the basolateral circuit
1991
Neurochemical abnormalities of the cerebral cortex in schizophrenia
1992